glp 1 for addiction treatment GLP-1 Drug Obesity drug cuts opiate craving
Description
"This discovery laid the foundation for every GLP-1 drug used today, starting with a poisonous lizard studied in 1984 ." How did exendin-4 become the first GLP-1 medication
10.1097/MS9.0000000000004189 Ann Med Surg
In the DURATION 1 trial, after week 30, 130 patients with T2D who had been randomised to exenatide twice daily 10 g were switched to exenatide ER 2.0 mg
The side effect data is clear on this point
They begin with the everyday choices on your plate and the rhythms of your daily life
Robert Kushner: The STEP trials were the phase three foundational clinical trials for Novo Nordisk that brought semaglutide to the market
